Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-02-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited under an ANDA. This confirms reg…
-
FDA approval · 2010-02-16FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) by Wyeth/Pfizer, updating the product labeli…
-
FDA approval · 2010-01-27FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company.
-
FDA approval · 2010-01-27FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride (generic) submitted by Amneal Pharmaceuticals of New York LLC under ANDA…
-
FDA approval · 2010-01-22FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental generic application for BUPROPION HYDROCHLORIDE by Amneal Pharmaceuticals of New York LLC under ANDA077415.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-01-06FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2009-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride, resulting in changes to the …
-
FDA approval · 2009-12-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Actavis Pharma, confirming approval of a generic version.
-
FDA approval · 2009-12-04FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA (olanzapine) filed by Eli Lilly and Company, expanding the regulatory scope of the produ…
-
FDA approval · 2009-11-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis, a generic sustained-release formulation.
-
FDA approval · 2009-11-09FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth/Pfizer, adding the extended-r…
-
FDA approval · 2009-11-09FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride extended-release (XL) from Actavis Pharma, enabling the generic prod…
-
FDA approval · 2009-11-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for bupropion hydrochloride (Epic Pharma LLC) under ANDA 075932. This approval updates the approved …
-
FDA approval · 2009-10-26FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for NORPRAMIN (desipramine hydrochloride) from Validus Pharmaceuticals LLC.
-
FDA approval · 2009-09-30FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic venlafaxine product manufactured by Heritage Pharmaceuticals (d/b/a Avet Pharmaceutica…
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., updating the approval status of the drug. Th…
-
FDA approval · 2009-09-28FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved the supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., confirming regulatory approval of…
-
FDA approval · 2009-09-28FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the generic drug citalopram from Mylan Pharmaceuticals Inc.
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine (generic) filed by Chartwell Governmental & Specialty RX, LLC. The approval confirms …
-
FDA approval · 2009-08-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, enabling the generic prod…
-
FDA approval · 2009-08-31FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for the extended-release form of Pristiq (desvenlafaxine succinate).
-
FDA approval · 2009-08-21FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for generic fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-08-21FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
FDA has approved a supplemental application for Citalopram from Cipla USA Inc.
-
FDA approval · 2009-08-07FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride).
-
FDA approval · 2009-07-22FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690, authorizing …